• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国呼和浩特909例感染奥密克戎BF.7变异株病例的临床特征:一项回顾性研究

Clinical characteristics of 909 cases infected by Omicron BF.7 variant in Hohhot of China: A retrospective study.

作者信息

An Caiyan, Zhang Kejin, Yang Xiaoguang, Fan Dongsheng, Ji Renhui, Yang Liuyi, Tong Xin, Jia Longlong, Wang Yanfang, Zhang Junjing

机构信息

Department of Allergy and General Surgery, Foundational and Translational Medical Research Center, Hohhot First Hospital, Hohhot, China.

Department of Biological Sciences, College of Life Science, Institute of Population and Health, Northwest University, Xi'an, China.

出版信息

Medicine (Baltimore). 2025 Jun 20;104(25):e42794. doi: 10.1097/MD.0000000000042794.

DOI:10.1097/MD.0000000000042794
PMID:40550086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12187311/
Abstract

A clinical survey on 909 patients with SARS-CoV-2 subvariant BF.7 infection was conducted in Hohhot First Hospital in Hohhot, China, from October 3 to October 22, 2022. Medical records of patients were reviewed by 2 physicians, respectively. The majority of cases (over 80%) showed mild symptoms, while 25% had a history of chronic medical illness or comorbidities, including cardiovascular and cerebrovascular diseases (14%), metabolic disease (7%), obesity (4%) and others. Common symptoms of BF.7 infection included cough (70%), sore throat (53%), expectoration (51%), and fever (41%). Around 75% of patients were discharged within 2 weeks of noninvasive mechanical ventilation and traditional Chinese medicine treatment. This study also resulted in that vaccination was ineffective against BF.7 virus infection, while elderly patients with incomplete COVID-19 vaccination and preexisting chronic diseases were at higher risk for moderate or severe BF.7 infection. In conclusion, this study analyzed clinical characteristics of patients infected by BF.7 virus, emphasizing the imperative to further explore effective vaccine and develop novel prevention and treatment strategies to cope with such a continuously mutating and evolving RNA virus infection and to minimize its threat and impact on human health, especially for vulnerable population.

摘要

2022年10月3日至10月22日,中国呼和浩特市第一医院对909例感染新型冠状病毒变异株BF.7的患者进行了一项临床调查。患者的病历分别由两名医生进行审查。大多数病例(超过80%)症状较轻,而25%的患者有慢性病史或合并症,包括心血管和脑血管疾病(14%)、代谢性疾病(7%)、肥胖症(4%)等。BF.7感染的常见症状包括咳嗽(70%)、咽痛(53%)、咳痰(51%)和发热(41%)。约75%的患者在无创机械通气和中医治疗2周内出院。该研究还得出结论,疫苗接种对BF.7病毒感染无效,而未完成新冠疫苗接种且患有慢性病的老年患者感染BF.7后出现中度或重度症状的风险更高。总之,本研究分析了BF.7病毒感染患者的临床特征,强调必须进一步探索有效的疫苗,制定新的预防和治疗策略,以应对这种不断变异和进化的RNA病毒感染,并尽量减少其对人类健康,特别是对弱势群体的威胁和影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/caf70d00319d/medi-104-e42794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/1b20b522cdb1/medi-104-e42794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/c3f718d44de2/medi-104-e42794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/caf70d00319d/medi-104-e42794-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/1b20b522cdb1/medi-104-e42794-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/c3f718d44de2/medi-104-e42794-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f08d/12187311/caf70d00319d/medi-104-e42794-g003.jpg

相似文献

1
Clinical characteristics of 909 cases infected by Omicron BF.7 variant in Hohhot of China: A retrospective study.中国呼和浩特909例感染奥密克戎BF.7变异株病例的临床特征:一项回顾性研究
Medicine (Baltimore). 2025 Jun 20;104(25):e42794. doi: 10.1097/MD.0000000000042794.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study.2022年中国北京灭活新型冠状病毒肺炎疫苗对奥密克戎BA.2.2感染的有效性:一项同居回顾性队列研究
Viruses. 2024 Dec 28;17(1):31. doi: 10.3390/v17010031.
4
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.SARS-CoV-2 中和单克隆抗体预防 COVID-19。
Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2.
5
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
6
Assessment of COVID-19 Vaccine Knowledge, Attitude and Practice among the General Population in Duhok Province, Kurdistan Region of Iraq: A Retrospective Cross-Sectional Study.伊拉克库尔德地区杜胡克省普通人群对新冠疫苗的知识、态度和实践评估:一项回顾性横断面研究
Arch Razi Inst. 2024 Dec 31;79(6):1241-1248. doi: 10.32592/ARI.2024.79.6.1241. eCollection 2024 Dec.
7
Real-world impact of COVID-19 vaccination, household exposure, and circulating SARS-CoV-2 variants on infection risk and symptom presentation in a U.S./Mexico border community.新冠疫苗接种、家庭暴露及循环的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体对美国/墨西哥边境社区感染风险和症状表现的现实世界影响
Front Public Health. 2025 Jun 9;13:1497390. doi: 10.3389/fpubh.2025.1497390. eCollection 2025.
8
A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients.一项关于 COVID-19 疫苗接种者和未接种者中早期抗生素使用的回顾性队列研究。
J Med Virol. 2024 Mar;96(3):e29507. doi: 10.1002/jmv.29507.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.

本文引用的文献

1
Diagnosis and treatment protocol for COVID-19 patients (Tentative 10th Version).新型冠状病毒肺炎诊疗方案(试行第十版)
Health Care Sci. 2023 Feb 23;2(1):10-24. doi: 10.1002/hcs2.36. eCollection 2023 Feb.
2
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1.接种两剂 SARS-CoV-2 疫苗加强针和感染过 COVID-19 后,血浆能有效中和 BQ.1.1 和 XBB.1.
J Gen Virol. 2023 May;104(5). doi: 10.1099/jgv.0.001854.
3
Urgent Need for Next-Generation COVID-19 Vaccines.对下一代新冠疫苗的迫切需求
JAMA. 2023 Jan 3;329(1):19-20. doi: 10.1001/jama.2022.22759.
4
An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain.一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域突变的抗体逃逸估计器。
Virus Evol. 2022 May 11;8(1):veac021. doi: 10.1093/ve/veac021. eCollection 2022.
5
The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值在 COVID-19 中的影响:系统评价和荟萃分析。
J Intensive Care Med. 2022 Jul;37(7):857-869. doi: 10.1177/08850666211045626. Epub 2021 Oct 21.
6
Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study.利用自我报告症状在英国早期检测 COVID-19:一项大规模、前瞻性、流行病学监测研究。
Lancet Digit Health. 2021 Sep;3(9):e587-e598. doi: 10.1016/S2589-7500(21)00131-X. Epub 2021 Jul 29.
7
Laboratory parameters and outcomes in hospitalized adults with COVID-19: a scoping review.住院 COVID-19 成人的实验室参数和结局:范围综述。
Infection. 2022 Feb;50(1):1-9. doi: 10.1007/s15010-021-01659-w. Epub 2021 Jul 10.
8
COVID-19 and Chronic Disease: The Impact Now and in the Future.新冠疫情与慢性病:当下及未来的影响
Prev Chronic Dis. 2021 Jun 17;18:E62. doi: 10.5888/pcd18.210086.
9
Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.COVID-19 重症和死亡的人群风险因素:一项全球系统回顾和荟萃分析。
PLoS One. 2021 Mar 4;16(3):e0247461. doi: 10.1371/journal.pone.0247461. eCollection 2021.
10
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.COVID-19 住院患者的肝脏疾病和结局 - 系统评价和荟萃分析。
Ann Hepatol. 2021 Mar-Apr;21:100273. doi: 10.1016/j.aohep.2020.10.001. Epub 2020 Oct 16.